Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-27

Clinical Trial Update: Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating the effect of liraglutide on weight loss and gastric functions in obesity has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAXENDA (liraglutide)
  • Victoza (Liraglutide)

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2017-10-27